CELGENE CORP /DE/ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CELGENE CORP /DE/.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CELGENE CORP /DE/. CELGENE CORP /DE/ is a in CELGENE CORP /DE/ ($CELG) and a 10% Owner in CELGENE CORP /DE/ ($CELG) and a 10% Owner in CASI Pharmaceuticals, Inc. ($CASI) and a 10% Owner in Alliqua BioMedical, Inc. ($ALQA) and a in ACCELERON PHARMA INC ($XLRN) and a 10% Owner in ACCELERON PHARMA INC ($XLRN) and a in SUTRO BIOPHARMA INC ($STRO) and a 10% Owner in Abraxis BioScience, Inc. ($ABII) and a 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and a 10% Owner in CRISPR Therapeutics AG ($CRSP).

Over the past year CELGENE CORP /DE/ has been an insider in 3 companies. The total value of shares held by CELGENE CORP /DE/ in these companies amounts to $955,455,900.

CELGENE CORP /DE/ 10% Owner
Abraxis BioScience, Inc.
ACCELERON PHARMA INC
10% Owner
Adynxx, Inc.
10% Owner
AGIOS PHARMACEUTICALS, INC.
10% Owner
CASI Pharmaceuticals, Inc.
CELGENE CORP /DE/
10% Owner
CRISPR Therapeutics AG
SUTRO BIOPHARMA, INC.
$ 955455900 The total value of shares held by CELGENE CORP /DE/
Insider Rank

CELGENE CORP /DE/ ranks 100 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 86 MORRIS AVENUE SUMMIT 07901 NJ

Companies in which CELGENE CORP /DE/ is an Insider

Abraxis BioScience, Inc.

Trading Symbol: ABII
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 100 shares
Latest Transaction: Oct 18 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/:
Holdings: 6,824,685 shares
Current Value: $162,018,022
Latest Transaction: Jan 22 2019
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,451,798
Shares Sold: 0
Share Difference: +1,451,798
Value Difference: -$57,953,762

Adynxx, Inc.

Trading Symbol: ALQA
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,342,377 shares
Current Value: $4,038,307
Latest Transaction: Apr 13 2017
$ALQA Market Capitalization: $17.78M
$ALQA Previous Close: $0.55

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 4,296,277
Shares Sold: 0
Share Difference: +4,296,277
Value Difference: -$2,000,000

AGIOS PHARMACEUTICALS, INC.

Trading Symbol: AGIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 1,374,599 shares
Current Value: $61,059,688
Latest Transaction: Jan 23 2018
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 851,154
Shares Sold: 0
Share Difference: +851,154
Value Difference: -$57,027,320

CASI Pharmaceuticals, Inc.

Trading Symbol: CASI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 23,750,000 shares
Current Value: $33,012,500
Latest Transaction: Apr 01 2005
$CASI Market Capitalization: $81.26M
$CASI Previous Close: $1.39

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CELGENE CORP /DE/

Trading Symbol: CELG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/:
Holdings: 6,824,685 shares
Current Value: $793,437,878
Latest Transaction: Jan 22 2019
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 21x
Shares Bought: 13,160,406
Shares Sold: 1,112,446
Share Difference: +12,047,960
Value Difference: -$107,065,062

CRISPR Therapeutics AG

Trading Symbol: CRSP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 4,812,221 shares
Current Value: $75,792,481
Latest Transaction: Dec 07 2017
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 21x
Shares Bought: 4,834,980
Shares Sold: 1,112,446
Share Difference: +3,722,534
Value Difference: +$9,916,020

SUTRO BIOPHARMA, INC.

Trading Symbol: STRO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/:
Holdings: 1,726,197 shares
Latest Transaction: Oct 02 2018

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 1,726,197
Shares Sold: 0
Share Difference: +1,726,197
Value Difference: $0

Latest Insider Trading Transactions of CELGENE CORP /DE/

Sentiment: All, ABII, XLRN, ALQA, AGIO, CASI, CELG, CRSP, STRO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 22 2019XLRNACCELERON PHARMA I ...CELGENE CORP /DE/BuyP43.00706,20630,366,8586,824,6856.1 M to 6.8 M (+11.54 %)
Jan 22 2019CELGCELGENE CORP /DE/CELGENE CORP /DE/BuyP43.00706,20630,366,8586,824,6856.1 M to 6.8 M (+11.54 %)
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/Option ExerciseC0.0018,726,07500
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/Option ExerciseC0.0018,097,33100
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/Option ExerciseC0.002,845,11400
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/Option ExerciseC0.008,338,89200
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/BuyC0.001,726,19701,726,1970 to 1.7 M

View all CELGENE CORP /DE/ insider transactions.